Semler Scientific Buys $25M in Bitcoin; Shares Slide 22%
Semler Scientific has added $25 million of Bitcoin to its corporate treasury, raising total BTC holdings to 4,846 coins valued at about $578 million. The medical technology firm acquired the new Bitcoin at an average price of $118,974 per coin in early July, financing the purchase through a $175 million at-the-market equity offering.
Despite its aggressive Bitcoin strategy, Semler Scientific’s stock has fallen 22% year-to-date amid investor concerns over share dilution and underwhelming Q2 earnings. Looking ahead, Semler Scientific plans to increase its Bitcoin treasury to 105,000 BTC by 2027 — roughly 0.05% of total BTC supply — funded by future equity raises.
The company also faces legal scrutiny from the U.S. Department of Justice following settlement talks over potential fraud violations involving its QuantaFlo product. Analysts warn that while Bitcoin adoption can enhance brand visibility, it may not resolve Semler Scientific’s operational challenges. This development underscores ongoing tension between corporate Bitcoin strategies and stock performance, prompting traders to weigh the risks of treasury diversification against market skepticism.
Neutral
Semler Scientific’s latest $25 million Bitcoin purchase highlights continued corporate adoption of BTC, which can be viewed as a bullish indicator for long-term demand. However, the relatively small size of the acquisition against total Bitcoin supply and the company’s ongoing stock dilution and legal uncertainties temper immediate market enthusiasm. In the short term, traders may remain cautious due to investor skepticism over equity financing and operational challenges. Over the long term, persistent corporate treasury diversification could support Bitcoin’s price floor, but legal and financial headwinds at Semler Scientific may limit broader bullish momentum.